PRRT2 p.Glu23Lys
c.67G>A · rs140383655 · VCV130039
⚠ Built without this gene's context — gene constraint and dosage, protein structure, pathways, panels and related-variant links were not looked up for this page. why
Computational evidence
| Protein change | ||
| AlphaMissense | 0.0771 | likely benign |
|---|---|---|
| REVEL | 0.059 | moderately benign-leaning |
| SaProt | LLR -8.37 | tolerated |
| ⇒ AlphaMissense, REVEL and SaProt all call this tolerated. | ||
| Splicing | ||
| SpliceAI | — | not looked up on this page · why |
| Constraint at this position | ||
| Conservation | phyloP 0.94 | GERP -2.5, phastCons 0.69 |
| Regional constraint | o/e 1.16 | unconstrained · MANE · 785 bp · p 0.003 · regional, not allelic |
| Overall | ||
| CADD | 13.9 | PHRED · no single calibrated threshold — expert panels disagree |
AlphaMissense carries the ACMG weight for missense; REVEL and SaProt are independent agreement signals.
Population frequency
| Ancestry group | Frequency | 1 in |
|---|---|---|
| European (non-Finnish)grpmax | 0.248% | 403 |
| Remaining individualsnot grpmax-eligible | 0.206% | 484 |
| Admixed American | 0.14% | 714 |
| African / African-American | 0.044% | 2,273 |
| Finnishnot grpmax-eligible | 0.0344% | 2,908 |
| South Asian | 0.00659% | 15,181 |
Rarity supports pathogenicity (ACMG PM2); frequency above a disease-specific BA1/BS1 threshold argues against it. A variant frequent in one ancestry group can be near-absent in others, so a single global figure can mislead.
Variant & gene context
- Gene
- PRRT2
- Protein
- p.Glu23Lys
- Coding
- c.67G>A
- MANE Select
- NM_145239
- dbSNP
- rs140383655
- Type
- single nucleotide variant
- Location
- chr16:29813121 (GRCh38)
Disease context
episodic kinesigenic dyskinesia 1 — disease report on Sugi Atlas → Associated genes, phenotypes, clinical trials & treatmentsAlso linked: infantile convulsions and choreoathetosisseizures, benign familial infantile, 2episodic kinesigenic dyskinesia
For Paroxysmal kinesigenic dyskinesia (Orphanet):
- Inheritance
- Autosomal dominant, Not applicable
- Onset
- Adolescent, Adult, Childhood, Infancy
- Prevalence
- 1-9 / 1 000 000 (Worldwide)
Built on 18 open, versioned datasets — ClinVar, gnomAD, AlphaMissense, REVEL, ClinGen & more — plus Sugi Variant's own cross-source analysis. Source data 2026-01–2026-10, ClinVar 2026-10. Full sources & versions →
Cite Sugi Variant
Gür T. Sugi Variant: A Deterministic Per-Variant Germline Reference from a Knowledge Graph for Humans and AI Agents. 2026. doi:10.5281/zenodo.21509445. This variant: https://sugi.bio/variant/prrt2-p-glu23lys (accessed [today's date]).
Preprint & method: sugi.bio/variant/method Machine-readable: this page as Markdown